chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from an immunization official referring to an unspecified number patients of unknown demographics. No information regarding the patients' pertinent medical history and drug reactions or allergies was reported. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX (lot# M041080, expiration date: 06-OCT-2018; dose, route of administration and anatomical location were not provided) for prophylaxis. A sterile diluent (manufacturer unknown) used to reconstitute the vaccine was stored properly. The vaccine was stored at the temperature of 41.5 degrees Fahrenheit (F) (between 15 F and 46 F) for 18 hours and at 25.5 F for 15 hours and 58 minutes. No previous temperature excursions were reported. Data logger was involved. No adverse effects were reported. No product quality complaint was involved.
Pt came in on 9-21-2017 to report a problem with her vaccine. She had shoulder pain at the site of the injection. She went to her doctor and he said she had a lacerated shoulder.
Administer expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) in a 41-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine). On 29-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment  was given to patient.
pt recvd vax;had 10 days of diffuse distal proximal lt arm pain;motor sensory,pulse;joint exams were nl;no crepitus;provisional dx was tendonitis;cont to adm naprosyn (alleve),added warm soaks;sxs gradually resolved over 2 1/2-3 wks;
COVID - low grade fever for 2 days, achy 2 days, tired 6 days, runny nose 5 days, headache 1 day.  Occasional cough continues and stuffy nose.
No adverse event; vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 19Jul2022; Administered the vaccine to 346 patients after the 30 day by used; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), NO ADVERSE EVENT (No adverse event) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 19Jul2022) in a 72-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 19-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 19-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 19Jul2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used), NO ADVERSE EVENT (No adverse event) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 19Jul2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine to 346 patients after the 30 day by used) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 4Jun2022 and administration of vaccine on 19Jul2022).    Concomitant medications were not reported.  They administered the vaccine to 346 patients after the 30 day by used and total Number of vials was 35. The vial did not undergo any temperature excursions. Treatment medications were not reported.
Gave Tdap and Td was the correct vaccine as he was receiving his 2nd dose. Tdap given in January. Noted error next day when vaccine history was noted by the reporter
THE NIGHT OF VACCINATION DAY, RESIDENT BEGAN C/O SEVERE PAIN IN THE INJECTION ARM.  THE DAY AFTER THE VACCINE,  HE BEGAN HAVING MOOD ISSUES, VERBAL AGGRESSION/OUTBURSTS (ABNORMAL FOR THIS RESIDENT), DIZZINESS AND A SEVERE HEADACHE HE RATED AT 10/10 PER PAIN SCALE THAT DID NOT RESOLVE WITH SEVERAL DOSES OF PAIN MEDS.
Positive for COVID 12/16/22 even though I got my booster 19/5/22
Hives and itching-arrived at ER 11:50AM. Given Solumedrol 125mg IV. 3 1:1000 epi sq. Benadryl 12.5mg IV. Released at 14:05.
Vertigo for 4 weeks after getting second shot Feb 24,2021; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an 24Feb2021 (at the age of 71-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure abnormal. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included unspecified medications for blood pressure from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN9581) via an unspecified route of administration in the left arm on 03Feb2021 at 02:00 (at the age of 71-year-old) as a single dose for COVID-19 immunisation. On 05Apr2021, the patient experienced vertigo for 4 weeks after getting second shot 24Feb2021. Since the vaccination, the patient had not been tested for COVID-19. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of vertigo and included treatment with dizzy pills and a head scan. The clinical outcome of the event vertigo for 4 weeks after getting second shot 24Feb2021 was resolved with sequelae on an unknown date in Apr2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Patient received IM Shingrix vaccine 3/2/20 in L arm. On 3/4/20 patient spoke with MD on phone, reported on 3/2/30 arm was very sore, 3/3/20 experienced severe fatigue/joint pain and had to leave work to rest. MD discussed risk/benefit of receiving second dose, patient elected to receive second dose. Patient received second dose 8/3/20, no indication of another ADR.
pt. recvd. vax & developed measles rash,cough,coryza,conjunctivitis,& Koplik spots.
Information has been received from an NP concerning a 9 year old child who was vaccinated with MMRII at the recommended age (approx. 1994). It was reported that "this past week, 2/11/02", the child was dx'd with mumps. Unspecified medical attention was sought. No further info was provided. Additional info has been requested.
Arm pain at injection site; Fever 100.8 max; Nausea; Vomiting; Diarrhea; Fatigue; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 3248) via an unspecified route of administration in the arm right on 30Mar2021 at 09:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to clindamycin (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the arm right on 09Mar2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021, the patient experienced arm pain at injection site, fever 100.8 max, nausea, vomiting, diarrhea, fatigue and body aches. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for events. The clinical outcome of the events arm pain at injection site, fever 100.8 max, nausea, vomiting, diarrhea, fatigue and body aches were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
hives, swelling of shoulder all the way down to elbow. itching and arm still hard from shoulder to elbow 30 days after vaccine.
Flu Like Symptoms after each dose; Really Sick after each dose; fever after each dose; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu Like Symptoms after each dose), ILLNESS (Really Sick after each dose) and PYREXIA (fever after each dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu Like Symptoms after each dose), ILLNESS (Really Sick after each dose) and PYREXIA (fever after each dose). At the time of the report, INFLUENZA LIKE ILLNESS (Flu Like Symptoms after each dose), ILLNESS (Really Sick after each dose) and PYREXIA (fever after each dose) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.   This case was linked to MOD-2021-406558, MOD-2021-406828 (Patient Link).
8/15/2021 Admit to hospital with breakthrough COVID. Cough, SOB, body aches and chest tightness. Diagnosed with COVID pneumonitis.   Note: patient previously vaccinated with Pfizer COVID-19 vaccine, 2nd dose on 5/5/21. 8/20/21: DIscharged on 2 weeks of outpatient IV antibiotics.
extreme lower back/ tailbone pain; extreme lower back/ tailbone pain; This is a spontaneous report from a contactable consumer (patient). A 37-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiry date unknown), via an unspecified route of administration, administered in arm left on 03Sep2021 08:15 as dose 1, single for covid-19 immunization. Medical history included allergies: penicillin. There were no concomitant medications. There were no other vaccines in four weeks. It was unknown if the patient had covid-19 prior to vaccination. The patient was not tested for covid-19 post-vaccination. The patient experienced extreme lower back/tailbone pain on 11Sep2021. No treatment was received for the events. The patient had not recovered from the events at the time of the report.
The infant's brain swelled. She died the next day. All the doctors did was run tests. They didn't do anything to try and save her. Autopsy report received states child died from bilateral subdural hematoma - homicide.
sore arm near injection site, whole body arthralgia,, muscle aches, fatigue, chills for ~ 36 hours beginning ~ 4-6 hours after the injection.  I took 600mg ibuprofen every 5 hours for 36 hours.  All symptoms resolved except arthralgia.  It never completely resolved.  My joints (knees, ankles, left wrist) which had previously been  intermittently painful are now never pain free.  I am nearly unable to walk from bilateral knee pain
3hr p/vax pt woke up screaming & crying-shrill, abn for >4hr;took pt to ER saw MD;pt crying & screaming w/pain @ home awoke from sleep crying;
Both DTaP #5, IPV #4 were given in the left thigh. No fever or breathing problems. At shot site the thigh was swollen, warm and erythematous. Site of reaction 11 x 7 1/2 cm. Child returns to clinic on Monday with complete resolvement of local skin reaction.
Donor states post tetanus toxoid injection received at 10:52 on 5-15-08 when he got home his shoulders began to ache moving down to hips and his body throbbed, legs felt light and tingled.  Donor states he has some trouble walking but denies any CP, SOB, rash, cramping, or other symptoms.  Donor reported it lasting about 30 minutes.
After initial "flu-like" symptoms subsided, which I was expecting, I noticed that the bottom of my feet were nonstop twitching. I also noticed that my left leg felt weak in an odd way. This continued for a few days, so I made an appointment with a neurologist for various tests (below). The muscle weakness has since spread to both legs (is now worse in my dominant right leg), and my right arm. The twitching in my feet has not subsided at all since April 2021. I have had other muscle twitching in my legs and a few other random places. I also experienced tingling and coldness and a very light sensation of my feet being "asleep" when walking on my feet. Not as bad as a foot actually being asleep.  I had never experienced any of this prior to the 2nd pfizer vaccination. It may have even started within 24 hours, but bc I had the flu-like symptoms, I wasn't noticing these other symptoms. It has now been 11 months and it remains. I cannot exercise like I used to due to this muscle weakness. I list this as "disability or permanent damage" because nothing has changed in 11 months. I hope this is not permanent, but at this point, there has been no improvement.
p/vax pt had hives both legs & lt arm (inj given lt deltoid);pt seen on 10/25/99 & pred prescribed;
I received the first covid vaccination in May 5th and a week or so later started getting tingling in my toes that would come and go.  I did not tie it to the vaccine at first as it was not a listed side effect I saw.  On 5/26/2021 I received the second shot and the tingling spread to more of my toes, and then into my hands a few days later.  After another few days my legs became very weak and I went into the Emergency Room where they diagnosed me with Guillain-Barre and my symptoms continued to worsen where I lost all my reflexes and ability to walk as usual
Second dose of bivalent booster given to patient. Patient notified. First bivalent booster given on 9/22/22.
Rash (mild) arms and back. Itchy. Evaluated by EMS- Refusal to Transport
Patient presenting approx 45 minutes after injection with facial swelling to eyelids and upper face. Also had an associated pruritic rash on right upper back region. No swelling to mouth, lips or tongue. No SOB or wheezing. Symptoms improved (decreased swelling) with 50mg PO benadryl. Was discharged after monitoring for 2 hours. Provided rx for epi pen upon discharge.
Itching began Thursday 1/21/2021. By Friday, my arm at the injection site became red, hot and very sensitive. By Saturday, it became even more swollen-2 1/2 x 3 1/2 inches. Sunday, it seemed to calm a bit. Today, Monday, it is still sensitive, pink, warm an not as sensitive.
pain in opposite arm (right)/sore arm; disoriented; sweating; lethargy; headache; I had fatigue; chills; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in opposite arm (right)/sore arm), DISORIENTATION (disoriented), HYPERHIDROSIS (sweating), LETHARGY (lethargy) and HEADACHE (headache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jan-2021, the patient experienced PAIN IN EXTREMITY (pain in opposite arm (right)/sore arm), DISORIENTATION (disoriented), HYPERHIDROSIS (sweating), LETHARGY (lethargy), HEADACHE (headache), FATIGUE (I had fatigue), CHILLS (chills) and ARTHRALGIA (joint pain). At the time of the report, PAIN IN EXTREMITY (pain in opposite arm (right)/sore arm), DISORIENTATION (disoriented), HYPERHIDROSIS (sweating), LETHARGY (lethargy), HEADACHE (headache), FATIGUE (I had fatigue), CHILLS (chills) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Flu shots make the patient sick and get the flu anyway; Flu shots make the patient sick and get the flu anyway; Initial information received on 07-Dec-2020 regarding an unsolicited valid non-serious social media case from a consumer (patient).  This case involved a patient of unknown demographics who reported that flu shots (INFLUENZA VACCINE) make the patient sick (illness) and get the flu anyway (influenza).  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date (Unknown latency) following the administration of INFLUENZA VACCINE, the patient reported that flu shots make the patient sick (illness) and get the flu anyway (influenza).   Details of laboratory data not reported.  It was not reported if the patient received a corrective treatment.  The event outcome was reported as unknown for both the event, at the time of reporting.  There will be no information available on the batch number for this case.
Information has been received from a nurse referring to a 60 years old female patient who was allergic to codeine. The patient's concomitant therapies included ZYRTEC, estradiol, COLACE and calcium. Concurrent conditions included diabetes mellitus, hypertension and hyperlipidemia. On 11-JAN-2019, the patient received one dose of PNEUMOVAX 23 (lot # R012550 and expiration date 25-JAN-2020) intramuscularly for prophylaxis. On 12-JAN-2019, the patient began experiencing blisters, redness and swelling at the injection site. The patient was treated with metronidazole cream (manufacturer unknown) and triamcinolone cream (manufacturer unknown) for the events. None of lab diagnostic/studies was performed. The patient sought medical attention and had physician visit. On 24-JAN-2019, the patient recovered from blisters, redness and swelling at the injection site. The causality between the events and PNEUMOVAX 23 was not provided.
Local reaction left posterior arm. Moderate swelling warmth, blanching erythema medical to vaccine site. Increase vascular markings.
30 patients received Monovalent Moderna Vaccine past the manufacturers expiration date; No adverse event; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (30 patients received Monovalent Moderna Vaccine past the manufacturers expiration date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (30 patients received Monovalent Moderna Vaccine past the manufacturers expiration date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (30 patients received Monovalent Moderna Vaccine past the manufacturers expiration date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (30 patients received Monovalent Moderna Vaccine past the manufacturers expiration date).    This case contains information for the 8th of 30 adult patients described by the reporter.  Concomitant Medication use information was not provided by reporter.  There were 13, 11, and 6 different doses were given. The 30 patients received Monovalent Moderna Vaccine past the manufacturer's expiration date.   The batch lot number was reported as 022D21A which was expired on 20 April 2022. The Lot number 033F21A which was expired on 08 April 2022. The Lot number 037C21A expired on 02 January 2022.  Treatment Medication use information was not provided by reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-703461 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-703461:Master case
She experienced metal taste in mouth and there was an initial tightening in her throat on 1st vaccine administered. Eventually went away. She is now having symptoms of chills, fever, aches, jabbing pain throughout the body. tiredness, fatigue, and no energy.
4 1/2 x 5in induration, warmth, and erythema right thigh. Pain medication and warm compresses.
since she had cold since Thursday; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received as first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: Unknown), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, Consumer stated that, I am calling because I am scheduled to have my second Covid Vaccine shot tomorrow. I have been battling a cold from the past week and had cold since Thursday, I am at the end of the cold. So, I just want to make sure, I can still get a shot even though I still have some symptoms of the cold. I am on the end of it not in the beginning. Outcome of the event was not recovered.     No follow-up attempts are possible; information about lot/batch number cannot be obtained.